Skip to main content
Navid Redjal, MD, Neurosurgery, Camden, NJ

NavidRedjalMDFAANS

Neurosurgery Camden, NJ

Brain & Spinal Tumor

Director of Neurosurgical Oncology

Dr. Redjal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Redjal's full profile

Already have an account?

  • Office

    3 Cooper Plz
    Rm 104
    Camden, NJ 08103
    Phone+1 856-342-3159
    Fax+1 732-790-0107

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Neurological Surgery, 2008 - 2015
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Surgery, 2008 - 2009
  • Harvard Medical School
    Harvard Medical SchoolClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2025
  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • American Board of Neurological Surgery Neurological Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma Patients
    Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 6th, 2021
  • KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to Treatment
    KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to TreatmentAugust 13th, 2019
  • Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma Patients
    Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 8th, 2021
  • Join now to see all

Professional Memberships